The shortage of available donor hearts continues to limit cardiac transplantation. For this
reason, strict criteria have limited the number of patients placed on the US waiting list to ≈6000 …

Aims We sought to determine the influence of genotype on clinical course and arrhythmic
outcome among arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C)-…

… Yuan, SD Russell unpublished data). Conversely, signals from the embryo sac serve to
stimulate pollen tube growth and maturation. However, the nature of this communication is …

Background Patients with advanced heart failure have improved survival rates and quality
of life when treated with implanted pulsatile-flow left ventricular assist devices as compared …

Background Cardiosphere-derived cells (CDCs) reduce scarring after myocardial infarction,
increase viable myocardium, and boost cardiac function in preclinical models. We aimed to …

Background The use of left ventricular assist devices is an accepted therapy for patients with
refractory heart failure, but current pulsatile volume-displacement devices have limitations (…

CO-CHAIRS: Feldman D: Minneapolis Heart Institute, Minneapolis, Minnesota, Georgia
Institute of Technology and Morehouse School of Medicine; Pamboukian SV: University of …

Continuous-flow left ventricular assist devices (LVAD) have emerged as the standard of
care for advanced heart failure patients requiring long-term mechanical circulatory support. …

Objectives : This study sought to evaluate the use of a continuous-flow rotary left ventricular
assist device (LVAD) as a bridge to heart transplantation. Background : LVAD therapy is an …

OBJECTIVE: The aim of this study was to evaluate the incidence, risk factors, and effect on
outcomes of right ventricular failure in a large population of patients implanted with continuous…